| [1] |
HE Xueru, FU Yuhao, XUN Xuejiao, CUI Yanjun, DONG Zhanjun.
Advances in uridine diphosphate glucuronosyltransferase-mediated drug interactions with tyrosine kinase inhibitors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 936-945.
|
| [2] |
LIU Lu, CHEN Xiaoyan.
Current status of clinical drug-drug interactions research of innovative small molecule drugs in China
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 863-875.
|
| [3] |
MENG Qiang, LIU Kexin.
Research status and prospect of transporter-mediated drug-drug interactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 876-888.
|
| [4] |
HAO Haiping.
Metabolic regulation and drug target discovery researches in China: Progress and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 955-963.
|
| [5] |
LU Zhi-hong, DONG Hui, LIU Ming-fu, FENG Da-peng, DONG Hai-long.
Effect site concentration of propofol for loss of consciousness under remifentanil target-controlled infusion
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 904-906.
|
| [6] |
YANG Guo-ying, MA Kai, WU Lan-xiang, ZHANG Wei, ZHOU Hong-hao.
Influence of allicin on the function of organic anion transporting polypeptide 1B1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(7): 749-753.
|
| [7] |
GAO Li-chen, ZHANG Wei, LIU Zhao-qian, FAN Lan, ZHOU Hong-hao.
Progress in clinical herb-drug interactions mediated by drug metabolism- related genes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(3): 346-351.
|
| [8] |
XIONG Qian, ZHANG Mi, ZHENG Qing-shan.
Quantitative evaluation of pharmacodynamic interactions on diaphoretic effects among the components of Mao-to in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(7): 763-767.
|
| [9] |
PENG Xiang-dong, Ding Jin-song, ZHOU Yan-bin, TAN Zhi-rong, ZHOU Hong-hao.
HPLC-MS-MS determination of ritodrine in the human plasma and its pharmacokinetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 287-291.
|
| [10] |
LIU Zhi-feng, ZHOU Hong-hao.
Research status quo and development of herbs and chemical medicines interactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(2): 214-219.
|
| [11] |
LI Qin, WANG Rui.
Genetic polymorghism of CYP2D6 and drug interactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(4): 369-374.
|
| [12] |
.
Effect of pantoprazole on Cytochrome P4501A2, N-acetyltransferase2,and xanthine oxidase activity in human
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(3): 296-299.
|
| [13] |
HU Guo-Hua.
Efficacy of Xiaoer-qingre-ning combined with Xiaoer-shuxiao-ganmao-ling in the treatment of children acute respiratory infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(2): 201-203.
|
| [14] |
LI Qin, ZHAO Yan, LIANG Yong-Guang, TANG Shao-Fen, GUO Rui-Chen.
Influence of nicotinylmethylamide on the pharmacokinetic parameters of cyclosporin A by HPLC
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(5): 443-445.
|
| [15] |
WANG Chang-Sheng, LIU Xiao-Ping, MA Zhang-Qing, SONG Jian-Guo.
Influence of probenecid on pharmacokinetics of cefaclor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(2): 130-133.
|
